Genetic architecture of hemoglobin F control

Current Opinion in Hematology

Volumn 16, Issue 3, 2009, Pages 179-186

  Menzel, Stephan ^a   Thein, Swee Lay ^a,b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c James Black Centre   (United Kingdom)

Author keywords

Genome wide association studies; Heterocellular hereditary persistence of fetal hemoglobin; Quantitative trait; Sickle cell; Thalassemia

Indexed keywords

BETA GLOBIN; HEMOGLOBIN F; SPACER DNA;

BETA THALASSEMIA; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME 20P; CHROMOSOME 6Q; GENE MAPPING; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC VARIABILITY; HEMOGLOBINOPATHY; HUMAN; MORBIDITY; MORTALITY; PHENOTYPIC VARIATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE GENETICS; QUANTITATIVE TRAIT LOCUS; REVIEW; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; FETAL HEMOGLOBIN; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HEMOGLOBINOPATHIES; HUMANS; POLYMORPHISM, GENETIC; QUANTITATIVE TRAIT, HERITABLE; THALASSEMIA;

EID: 67749114458     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328329d07a     Document Type: Review

References (56)

1. Stamatoyannopoulos G, Nienhuis AW. Hemoglobin switching. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, editors. The molecular basis of blood diseases, 2nd ed. Philadelphia: W.B. Saunders and Co.; 1994. pp. 107-155.
2. Wood WG. Hereditary persistence of fetal hemoglobin and delta beta thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. Cambridge, UK: Cambridge University Press; 2001. pp. 356-388.
3. Nagel RL, Platt OS. General pathophysiology of sickle cell anemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. Cambridge, UK: Cambridge University Press; 2001. pp. 494-526.
4. Labie D, Pagnier J, Lapoumeroulie C, et al. Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci U S A 1985; 82:2111-2114.
5. Weatherall DJ, Clegg JB. The thalassaemia syndromes. 4th ed. Oxford: Blackwell Science; 2001.
6. Thein SL, Weatherall DJ. A nondeletion hereditary persistence of fetal hemoglobin (HPFH) determinant not linked to the beta-globin gene complex. In: Stamatoyannopoulos G, Nienhuis AW, editors. Hemoglobin switching, part b: cellular and molecular mechanisms. New York: Alan R. Liss, Inc.; 1989. pp. 97-111.
7. Cappellini MD, Fiorelli G, Bernini LF. Interaction between homozygous beta (0) thalassaemia and the Swiss type of hereditary persistence of fetal haemoglobin. Br J Haematol 1981; 48:561-572.
8. Galanello R, Dessi E, Melis MA, et al. Molecular analysis of beta zerothalassemia intermedia in Sardinia. Blood 1989; 74:823-827.
9. Ho PJ, Hall GW, Luo LY, et al. Beta thalassemia intermedia: is it possible to consistently predict phenotype from genotype? Br J Haematol 1998; 100:70-78.
10. Betke K, Marti HR, Schlicht I. Estimation of small percentages of foetal haemoglobin. Nature 1959; 184:1877-1878.
11. Kleihauer E, Braun H, Betke K. Demonstration of fetal haemoglobin in erythrocytes on a blood smear. Klin Wochenschr 1957; 35:627-635.
12. Marti HR. Normal and abnormal human hemoglobins. Berlin: Springer Verlag; 1963.
13. Marti HR, Butler R. Increase of hemoglobin F and hemoglobin A2 in the Swiss population. Acta Haematol (Basel) 1961; 26:65-74.
14. Boyer SH, Belding TK, Margolet L, Noyes AN. Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults. Science 1975; 188:361-363.
15. Dover GJ, Boyer SH. Quantitation of hemoglobins within individual red cells: asynchronous biosynthesis of fetal and adult hemoglobin during erythroid maturation in normal subjects. Blood 1980; 56:1082-1091.
16. Economou EP, Antonarakis SE, Kazazian HHJ, et al. Variation in hemoglobin F production among normal and sickle cell adults is not related to nucleotide substitutions in the Gamma promoter regions. Blood 1991; 77:174-177.
17. Sampietro M, Thein SL, Contreras M, Pazmany L. Variation of HbF and F-cell number with the G-gamma Xmn I (C-T) polymorphism in normal individuals. Blood 1992; 79:832-833.
18. Zago MA, Wood WG, Clegg JB, et al. Genetic control of F cells in human adults. Blood 1979; 53:977-986.
19. Thein SL, Craig JE. Genetics of Hb F/F cell variance in adults and heterocellular hereditary persistence of fetal hemoglobin. Hemoglobin 1998; 22:401-414.
20. Miyoshi K, Kaneto Y, Kawai H, et al. X-linked dominant control of F-cells in normal adult life: characterization of the Swiss type as hereditary persistence of fetal hemoglobin regulated dominantly by gene(s) on X chromosome. Blood 1988; 72:1854-1860.
21. Garner C, Tatu T, Reittie JE, et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 2000; 95:342-346.
22. Falconer DS, Mackay TFC. Introduction to quantitative genetics. 4th ed. Longman Group Ltd; 1996.
23. Old JM, Ayyub H, Wood WG, et al. Linkage analysis of nondeletion hereditary persistence of fetal hemoglobin. Science 1982; 215:981-982.
24. Stamatoyannopoulos G, Wood WG, Papayannopoulou T. A new form of hereditary persistence of fetal hemoglobin in blacks and its association with sickle cell trait. Blood 1975; 46:683-692.
25. S gene: origins, genetic epidemiology, and epistasis in sickle cell anemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. Cambridge, UK: Cambridge University Press, Cambridge, UK; 2001. pp. 711-755.
26. Gilman JG, Huisman THJ. DNA sequence variation associated with elevated fetal Gg globin production. Blood 1985; 66:783-787.
27. Thein SL, Wainscoat JS, Sampietro M, et al. Association of thalassaemia intermedia with a beta-globin gene haplotype. Br J Haematol 1987; 65:367-373.
28. Gγ expression. Blood 1985; 66:1463-1465.
29. Efremov GD, Gjorgovski I, Stojanovski N, et al. One haplotype is associated with the Swiss type of hereditary persistence of fetal hemoglobin in the Yugoslavian population. Hum Genet 1987; 77:132-136.
30. Garner C, Tatu T, Game L, et al. A candidate gene study of F cell levels in sibling pairs using a joint linkage and association analysis. GeneScreen 2000; 1:9-14.
31. Pissard S, Beuzard Y. A potential regulatory region for the expression of fetal hemoglobin in sickle cell disease. Blood 1994; 84:331-338.
32. S chromosomes with five different haplotypes. Blood 1991; 77:2488-2496.
33. Gianni AM, Bregni M, Cappellini MD, et al. A gene controlling fetal hemoglobin expression in adults is not linked to the nonalpha globin cluster. EMBO J 1983; 2:921-925.
34. Martinez G, Novelletto A, Di Rienzo A, et al. A case of hereditary persistence of fetal hemoglobin caused by a gene not linked to the β-globin cluster. Hum Genet 1989; 82:335-337.
35. Giampaolo A, Mavilio F, Sposi NM, et al. Heterocellular HPFH: molecular mechanisms of abnormal g gene expression in association with b thalassemia and linkage relationship with the b globin gene cluster. Hum Genet 1984; 66:151-156.
36. Garner C, Mitchell J, Hatzis T, et al. Haplotype mapping of a major QTL for fetal hemoglobin production on chromosome 6q23. Am J Hum Genet 1998; 62:1468-1474.
37. Close J, Game L, Clark BE, et al. Genome annotation of a 1.5Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adults. BMC Genomics 2004; 5:33.
38. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273:1516-1517.
39. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000; 405:847-856.
40. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008; 40:695-701.
41. Thein SL, Menzel S, Peng X, et al. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Natl Acad Sci U S A 2007; 104:11346-11351.
42. Uda M, Galanello R, Sanna S, et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci U S A 2008; 105:1620-1625. Second genome-wide association study based on HbF showing association of HbF to the three major QTLs and first replication in patients with SCA and β thalassemia.
43. Lettre G, Sankaran VG, Bezerra MA, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci U S A 2008; 105:11869-11874.
44. So J, Song YQ, Tsang S, et al. The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta thalassaemia. J Med Genet 2008; 45:745-751.
45. Creary LE, Ulug P, Menzel S, et al. Genetic variation on chromosome 6 influences F cell levels in healthy individuals of African descent and HbF levels in sickle cell patients. PLoS ONE 2009; 4:e4218.
46. Menzel S, Garner C, Gut I, et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet 2007; 39:1197-1199. First genome-wide association study reporting linkage of the three major HbF/F cell QTLs.
47. Sedgewick AE, Timofeev N, Sebastiani P, et al. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol Dis 2008; 41:255-258.
48. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678.
49. Creary LE, McKenzie CA, Menzel S, et al. Ethnic differences in F cell levels in Jamaica: a potential tool for identifying new genetic loci controlling fetal haemoglobin. Br J Haematol 2009 [Epub ahead of print].
50. Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 2008; 322:1839-1842.
51. Wallrapp C, Verrier S-B, Zhouravleva G, et al. The product of the mammalian orthologue of the Saccharomyces cerevisiae HBS1 gene is phylogenetically related to eukaryotic release factor 3 (eRF3) but does not carry eRF3-like activity. FEBS Lett 1998; 440:387-392.
52. Emambokus N, Vegiopoulos A, Harman B, et al. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J 2003; 22:4478-4488.
53. Vegiopoulos AP, Garcia P, Emambokus N, Frampton J. Coordination of erythropoiesis by the transcription factor c-Myb. Blood 2006; 107:4703-4710.
54. Jiang J, Best S, Menzel S, et al. cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 2006; 108:1077-1083.
55. Menzel S, Jiang J, Silver N, et al. The HBS1L-MYB intergenic region on chromosome 6q23.3 influences erythrocyte, platelet, and monocyte counts in humans. Blood 2007; 110:3624-3626.
56. Stamatoyannopoulos G. Control of globin gene expression during development and erythroid differentiation. Exp Hematol 2005; 33:259-271.